While these findings have yet to be reproduced, the report of an association between RET expression and HER2-positive Luminal B tumors [56], in combination with this initial functional characterization, suggest that RET may be a useful target in multiple subtypes of breast cancer. This evidence concerns the gene ERBB2 and breast cancer.